Key Content and Findings: We summarized the current status of treatment for advanced TNBC from four aspects: immunotherapy, targeted therapy, antibody-drug conjugates (ADC) drug therapy and chemotherapy. In addition, the 2021–2022 guidelines in the part of treatment for advanced TNBC were downloaded on the official website of the guidelines referred to, which were summarized meanwhile. Methods: We searched literatures related to the treatment for advanced TNBC from 2014 to 2022 on PubMed and sorted out them.
Keynote 355 os update#
As immunotherapy and precision therapy based on biomarkers have brought a new era to TNBC, it has become more crucial for clinicians to update the recommended treatment regimens for advanced TNBC patients. Policy of Dealing with Allegations of Research Misconductīackground and Objective: The encouraging results of clinical trials for triple-negative breast cancer (TNBC) patients in recent years have gradually formed a system for the therapeutic regimen.
0 kommentar(er)
